Our Vision
NanoBiotec LLC (dba PicoImmune) offers ultra-sensitive, multiplex and reliable bioassay services for real-time monitoring of protein and gene changes in minute samples from cells, animals, and patients, thereby expediting the discovery and development of novel therapeutics.
Our Mission
To efficiently accelerate the translation of high-caliber innovations into therapeutics by extracting max information from minute samples, aiming to benefit our patients today rather than in the future.
Our Team
Our team possesses extensive expertise in drug discovery and unparalleled proficiency in bioanalytical, cytometric, genomic, and proteomic techniques. We harness the power of ultra-sensitive pico-scale and multiplex immunoassay as well as microarray technologies. Our employees have received training at prestigious institutions such as MIT, NIH, MSKCC, Rutgers, NYU, Duke and have accumulated decades of experience working for multinational biopharma companies including Novartis, Sanofi, Merck, BMS/Celgene, and Regeneron. We acquire and analyze data from multi-level experiments to assess drug efficacy while elucidating the underlying mechanisms of drugs and diseases.
Partnering
PicoImmune is a privately held contract research organization (CRO) committed to enhancing the efficiency of discovering innovative therapeutic drugs. We offer cost-effective services to biopharma and academic investigators, aiming to expedite the development of novel drugs and personalized medicine for cancer, autoimmune, and various other unmet medical conditions. Our strategic focus lies in establishing R&D partnerships with biotech, pharma, diagnostic companies, as well as academic institutions. PicoImmune welcomes proposals for R&D collaboration and strategic partnerships. For further information, please contact us at hello@picoimmune.com.
